Skip to main content

Table 3 Multivariable analysis for DFS in the validation cohort

From: Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment

Variables

HR

95% CI

p value

Age

0.981

0.951–1.012

0.232

cTNM stage (III vs II)

   

IIIa-b vs II

1.092

0.510–2.339

0.820

IIIc vs II

1.884

0.752–4.717

0.176

pCR (Yes vs No)

1.022

0.456–2.295

0.957

IMNI (Yes vs No)

1.427

0.702–2.904

0.326

HR (HR + vs HR −)

1.297

0.553–3.041

0.550

HER2 (HER2 + vs HER2 −)

1.085

0.495–2.380

0.839

Radiomics score

1.002

1.000–1.005

0.042

  1. HR hormonal receptor, HER2 human epidermal growth factor receptor 2, IMNI internal mammary node irradiation